BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7912801)

  • 21. Hepatitis C and immune globulin.
    Prince AM; Horowitz B
    N Engl J Med; 1995 May; 332(18):1236; author reply 1236-7. PubMed ID: 7700325
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatitis C virus transmission by intravenous immunoglobulin.
    Farrugia A; Walker E
    Lancet; 1995 Aug; 346(8971):373; author reply 374-5. PubMed ID: 7542718
    [No Abstract]   [Full Text] [Related]  

  • 23. Viral transmission by blood products: a perspective of events covered by the recent tribunal of enquiry into the Irish Blood Transfusion Board.
    Yap PL
    Ir Med J; 1997; 90(3):84, 86, 88. PubMed ID: 9183082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus transmission by intravenous immunoglobulin.
    James RC; Mosley JW
    Lancet; 1995 Aug; 346(8971):374; author reply 374-5. PubMed ID: 7542719
    [No Abstract]   [Full Text] [Related]  

  • 25. Infectious hazards of immune globulin.
    Barton LL
    J Pediatr; 1995 Feb; 126(2):321-2. PubMed ID: 7844688
    [No Abstract]   [Full Text] [Related]  

  • 26. Experimental experience with virus validation studies.
    Willkommen H
    Dev Biol Stand; 1996; 88():317-8. PubMed ID: 9119155
    [No Abstract]   [Full Text] [Related]  

  • 27. Intravenous immunoglobulins.
    Webster AD
    BMJ; 1991 Aug; 303(6799):375-6. PubMed ID: 1912799
    [No Abstract]   [Full Text] [Related]  

  • 28. Safety of IVIG made from HCV-antibody-screened plasma.
    Schiff P; Kemp A
    Lancet; 1991 Oct; 338(8774):1076. PubMed ID: 1681376
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin.
    Bjøro K; Frøland SS; Yun Z; Samdal HH; Haaland T
    N Engl J Med; 1994 Dec; 331(24):1607-11. PubMed ID: 7526215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies to hepatitis C virus in human immunoglobulins: clinical meaning and diagnostic difficulties in children undergoing bone marrow transplant.
    Mateos ML; Camarero C; Maldonado S; Lasa E; Otheo E; Muñoz A
    Bone Marrow Transplant; 1994 Jul; 14(1):95-7. PubMed ID: 7524908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of intravenous immunoglobulin with regard to hepatitis C virus.
    Yu MW; Mason BL; Guo ZP; Tankersley DL
    Clin Ther; 1996; 18 Suppl B():71-2. PubMed ID: 8930443
    [No Abstract]   [Full Text] [Related]  

  • 32. Safety of intravenous immunoglobulin treatment.
    Atrah HI; Crawford RJ; Dow BC; Mitchell R
    J Clin Pathol; 1985 Oct; 38(10):1192-3. PubMed ID: 3932489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Who dies with hepatitis C virus in France?].
    Association nationale des gastroentérologues des hôpitaux généraux
    Gastroenterol Clin Biol; 2001 Apr; 25(4):347-52. PubMed ID: 11449122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From the Centers for Disease Control and Prevention. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
    JAMA; 1994 Aug; 272(6):424-5. PubMed ID: 8040966
    [No Abstract]   [Full Text] [Related]  

  • 35. Intravenous immunoglobulin therapy.
    Chapel H
    QJM; 1996 Sep; 89(9):641-3. PubMed ID: 8917738
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up.
    Christie JM; Healey CJ; Watson J; Wong VS; Duddridge M; Snowden N; Rosenberg WM; Fleming KA; Chapel H; Chapman RW
    Clin Exp Immunol; 1997 Oct; 110(1):4-8. PubMed ID: 9353141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unusual course of the hepatitis C virus infection in one patient diagnosed of common variable immunodeficiency.
    Múñoz FJ; de la Calle A; Giménez MJ; González J; Conde J
    Allergol Immunopathol (Madr); 1995; 23(6):263-6. PubMed ID: 8579003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoglobulins and hepatitis C virus.
    Thomas DP
    Lancet; 1990 Jun; 335(8704):1531. PubMed ID: 1972462
    [No Abstract]   [Full Text] [Related]  

  • 39. Low rate of HCV transmission from women infected with contaminated anti-D immunoglobulin to their family contacts.
    Sachithanandan S; Fielding JF
    Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):47-50. PubMed ID: 9265578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Side-effects of intravenous immune globulins.
    Duhem C; Dicato MA; Ries F
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):79-83. PubMed ID: 8033440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.